Subtotal $0.00
Shop Now
How long does Ozempic take to work depends on what “work” means. According to its label, semaglutide reaches peak blood levels 1 to 3 days after each weekly injection and settles at steady levels after 4 to 5 weeks. Blood sugar starts to fall early, but the first weeks are a starting step meant to limit side effects, and the main diabetes trials judged HbA1c after 30 weeks or more. For weight, which is Wegovy’s approved use rather than Ozempic’s, average loss built up over months: about 10.6% after 20 weeks in one trial’s run-in and 14.9% after 68 weeks in another. Results vary a lot between people.
Peptide Labs does not sell Ozempic, Wegovy, Zepbound or any prescription drug. This article is general information, not medical advice. A prescriber decides when and how to review progress.
Key Takeaways
- Semaglutide injections peak 1 to 3 days after each weekly shot and reach steady levels after 4 to 5 weeks (Ozempic label).
- Tirzepatide (Zepbound, Mounjaro) peaks about a day after each shot and reaches steady levels after about 4 weeks.
- Labels start low and raise the strength over weeks, and the starting step is not meant to be the working strength.
- HbA1c reflects about 3 months of blood sugar, which is why diabetes trials measured it at 26 to 40 weeks.
- In the weight trials, average loss kept growing for more than a year: 14.9% at 68 weeks (Wegovy) and 15% to 21% at 72 weeks (Zepbound).
- Digestive side effects usually appear early, mostly while the strength is being increased.
How long does Ozempic take to work? A timeline from labels and trials
The table gathers the timing facts that the labels and the main trials actually report. Trial figures are group averages, not predictions for any one person.
| Time after starting | What happens or was measured | Source |
|---|---|---|
| 1 to 3 days | Peak semaglutide level after each weekly injection | Ozempic and Wegovy labels |
| 4 to 5 weeks | Semaglutide reaches steady levels in the blood | Ozempic label |
| About 4 weeks | Tirzepatide reaches steady levels | Zepbound label |
| 12 weeks | Fasting glucose 22% lower than placebo in a lab study | Ozempic label |
| 20 weeks | Average weight loss 10.6% among people who reached the maintenance strength | STEP 4 run-in (Wegovy) |
| 30 weeks | HbA1c down about 1.5 points from 8.05% | SUSTAIN 1 (Ozempic) |
| 36 weeks | Average weight loss 20.9% among people who completed the lead-in | SURMOUNT-4 (Zepbound) |
| 68 weeks | Average weight loss 14.9% vs 2.4% on placebo | STEP 1 (Wegovy) |
| 72 weeks | Average weight loss 15.0% to 20.9% vs 3.1% on placebo | SURMOUNT-1 (Zepbound) |
What the label says about timing in the body
The Ozempic label, revised in May 2026, says that 89% of an injected amount reaches the bloodstream, that levels peak 1 to 3 days after each injection and that steady levels are reached after 4 to 5 weeks of weekly use. With a half-life of about one week, semaglutide stays in the circulation for about 5 weeks after the last injection. The Wegovy label gives the same peak timing and says semaglutide remains for about 5 to 7 weeks after the last injection, which is why it advises stopping at least 2 months before a planned pregnancy.
Steady levels at the starting strength are not the same as full effect, though, because the strength is increased in steps.
Why the first weeks can feel slow
Every GLP-1 label in this article starts low and raises the strength gradually over weeks, to reduce nausea and other digestive side effects. The labels are explicit that the first step is a starting point. The Ozempic label lists its starting step separately from the strengths used for blood sugar control. The label for Rybelsus and Ozempic tablets says the starting strength “is not effective for glycemic control”, and the Zepbound label says its starting strength is for starting and is not approved for ongoing use. The Wegovy and Zepbound labels tell prescribers to consider response and tolerability when choosing the ongoing strength. We did not find a fixed week for judging response in either label.
When does Ozempic start working on blood sugar?
Semaglutide lowers blood sugar from the start of use, but the effect grows as the strength rises. The Ozempic label’s lab studies were done after 12 weeks, including the escalation period: compared with placebo, fasting glucose was 22% lower, glucose two hours after a meal 36% lower and average 24-hour glucose 22% lower.
HbA1c, the main diabetes measure, reflects average blood sugar over about the past 3 months, according to the National Institute of Diabetes and Digestive and Kidney Diseases. It changes slowly by design, which is why trials measure it at 26 to 40 weeks. In SUSTAIN 1, a Novo Nordisk trial of 388 adults whose type 2 diabetes was managed by diet and exercise alone, HbA1c fell by 1.45 and 1.55 points on two semaglutide strengths and by 0.02 points on placebo after 30 weeks, from an average of 8.05%. Weight fell by 3.7 and 4.5 kg vs 1.0 kg. Ozempic is not FDA-approved for weight management; Wegovy vs Ozempic explains the two brands.
How long does Wegovy take to work for weight loss?
Two Novo Nordisk trials of Wegovy injection in adults without diabetes give the clearest picture:
- STEP 4 (JAMA 2021) gave semaglutide to 902 adults for a 20-week run-in: 16 weeks of escalation and 4 weeks at the maintenance strength. The 803 who reached that strength had lost 10.6% of body weight on average. This figure only includes people who stayed on and tolerated the drug.
- STEP 1 (NEJM 2021) followed 1,961 adults for 68 weeks. Average weight change was -14.9% with semaglutide and -2.4% with placebo. 86.4% lost at least 5%, 69.1% at least 10% and 50.5% at least 15%, which also means about 1 in 7 lost less than 5%.
In STEP 4, people who kept taking semaglutide after week 20 lost a further 7.9% by week 68, while those switched to placebo regained 6.9%. Loss therefore continued well past the escalation period, and stopping led to regain.
How long does Zepbound take to work?
The Zepbound label, revised in August 2026, says tirzepatide reaches peak levels a median of 24 hours after each weekly injection (range 8 to 72 hours), steady levels after 4 weeks, and has a half-life of about 5 to 6 days in people with overweight or obesity. It also notes that tirzepatide’s slowing of stomach emptying is largest after the first injection and fades over time.
- SURMOUNT-1 (NEJM 2022, supported by Eli Lilly) followed 2,539 adults without diabetes for 72 weeks, including a 20-week escalation period. Average weight change was -15.0%, -19.5% and -20.9% on three strengths vs -3.1% on placebo, and 85% to 91% lost at least 5%.
- SURMOUNT-4 (JAMA 2024, a Lilly trial) gave tirzepatide to 783 adults for a 36-week open-label lead-in; the 670 who completed it had lost 20.9% on average. Those who continued lost a further 5.5% by week 88, while those switched to placebo regained 14.0%.
Zepbound and Mounjaro are the same drug with different approved uses; see Mounjaro vs Zepbound.
Daily tablets and how fast they act
Oral semaglutide peaks about one hour after each tablet but, like the injection, takes 4 to 5 weeks to reach steady levels, and its labels also start low. The tablets have strict empty-stomach rules because only about 1% to 2% is absorbed; see our guides to the Wegovy pill and Ozempic tablets. Foundayo (orforglipron) is a small-molecule GLP-1 pill that can be taken with or without food. Its label gives peak levels 4 to 8 hours after each tablet, a half-life of about 29 to 49 hours and steady levels after about one week, and its main weight trials ran 72 weeks. Our Foundayo guide covers the results.
Side effects usually come first
Many people notice side effects before results. In STEP 1, nausea and diarrhea were the most common adverse events and were typically mild to moderate, temporary and eased with time. In SURMOUNT-1, digestive events occurred mainly during escalation. The Ozempic and Zepbound labels both warn that vomiting or diarrhea can cause dehydration and kidney injury, especially when starting and when the strength is increased. Our guides to semaglutide side effects and tirzepatide side effects list each label’s figures.
Why results vary
The trial averages hide a wide spread. Some people lost more than 20% of body weight while others lost less than 5%, and the labels themselves pair these drugs with a reduced-calorie diet and more physical activity. Tolerating the higher strengths, other medicines and health conditions all play a part. Our guide to eating on GLP-1 medicines covers the nutrition side, and for a side-by-side of the two leading drugs see Trulicity vs Ozempic and semaglutide vs tirzepatide.
Frequently Asked Questions
How long does Ozempic take to work for blood sugar?
Blood sugar begins to fall in the first weeks, and the label’s lab studies at 12 weeks showed fasting glucose 22% lower than placebo. HbA1c changes more slowly; in SUSTAIN 1 it fell about 1.5 points after 30 weeks.
When does Ozempic start working?
Semaglutide reaches peak levels 1 to 3 days after the first injection, but the first weeks use a starting strength meant to limit side effects. Steady levels take 4 to 5 weeks of weekly use.
How long does Wegovy take to work for weight loss?
In STEP 4, people who reached the maintenance strength had lost 10.6% on average after 20 weeks. In STEP 1, average loss at 68 weeks was 14.9% vs 2.4% on placebo.
How long does Zepbound take to work?
Tirzepatide reaches steady levels after about 4 weeks. In SURMOUNT-1, average weight loss at 72 weeks was 15.0% to 20.9% depending on strength, vs 3.1% on placebo.
Why do side effects start before the weight loss?
Digestive effects such as nausea are linked to slowed stomach emptying, which the labels say is strongest early on. Weight loss builds gradually over months.
How long does Ozempic stay in your system?
The Ozempic label says semaglutide remains in the circulation for about 5 weeks after the last injection; the Wegovy label says about 5 to 7 weeks.
Peptide Labs does not sell these drugs. This article is general information, not medical advice. Read the Medication Guide that comes with a prescription, and ask a pharmacist or prescriber how this information applies to you.
Last reviewed September 2026.
Related guides: Wegovy vs Ozempic: Same Semaglutide, Different Labels, Mounjaro vs Zepbound: Same Tirzepatide, Different Approvals, GLP-1 Diet: What Experts Recommend While on GLP-1 Medicines, GLP-1 for Weight Loss: What the Trials Actually Showed, Ozempic Not Working? Reasons Backed by Trial and Label Data, Ozempic Before and After: What the Trial Data Really Show.